BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6650958)

  • 1. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioavailability of phenylbutazone in the horse.
    Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
    Williams RJ; Smith JA; Boudinot FD; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of phenobarbital in horses after single and repeated oral administration of the drug.
    Knox DA; Ravis WR; Pedersoli WM; Spano JS; Nostrandt AC; Krista LM; Schumacher J
    Am J Vet Res; 1992 May; 53(5):706-10. PubMed ID: 1524295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin pharmacokinetics, bioavailability, efficacy, and dosage regimens in the horse.
    Button C; Gross DR; Johnston JT; Yakatan GJ
    Am J Vet Res; 1980 Sep; 41(9):1388-95. PubMed ID: 7447132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.